Form 8-K - Current report:
SEC Accession No. 0001493152-25-009684
Filing Date
2025-03-10
Accepted
2025-03-10 16:05:26
Documents
13
Period of Report
2025-03-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43021
  Complete submission text file 0001493152-25-009684.txt   218165

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocx-20250304.xsd EX-101.SCH 3012
3 XBRL LABEL FILE ocx-20250304_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocx-20250304_pre.xml EX-101.PRE 24164
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3537
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 25723662
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)